There is a vaccine for detoxification

The anti-drug vaccine has been developed by a team of researchers at Weill Cornell Medical College (New York). They are the first to test a new treatment against addiction.

>>>Vaccines help reduce heroin addiction

Ronald Crystal, the head of the research team, said: 'Drug addiction is a social evil and difficult to prevent. If we can successfully develop an anti-addiction vaccine, it will have a very positive society. ' Scientists have successfully conducted experiments on mice and monkeys.

The first vaccine uses harmless viruses to activate the body's immune system before a cocaine-like molecule. Since then, cocaine antibodies have been produced. The latest work on this vaccine was presented on June 12 at the annual meeting of the Nuclear Medicine Association held at Miami Beach.

Picture 1 of There is a vaccine for detoxification
Scientists have found vaccines that promise to help with drug addiction.

This vaccine has been tested in monkeys and obtained very positive feedback. Four months after the vaccination, the monkeys have gradually recovered.

The second vaccine uses gene therapy. Scientists injected a virus into rat liver cells. Since then, these cells began producing antibodies against cocaine.

This study was published on June 18 in Humane Gene Therapy Magazine. Research results show that the detoxification effect of this vaccine lasts at least 17 weeks.

In both cases, the antibodies produced by both vaccines work very efficiently and quickly, enough to detect drugs when it enters the system. This is a very important factor because drug addiction is caused by physiological effects created in the brain.

However, scientists are also concerned that drug addicts will buy vaccines in large numbers to get rid of addiction as soon as possible. This can make the vaccine ineffective.

The team is still working to test the toxicity of the vaccine when tested in animals before they can switch to human trials. Crystal said the team hopes to test the vaccine in humans within a year.

Thomas Kosten, a researcher from Baylor College of Medicine, who was not involved in the study, shared his opinion with Live Science that, despite not putting much hope into human experiments, he still Hope Crystal can succeed.